PetMed Express (NASDAQ: PETS) reported Q2 EPS of $0.11, $0.15 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $59.6 million versus the consensus estimate of $66 million.

For earnings history and earnings-related data on PetMed Express (PETS) click here.